Lexington, KY, October 6, 2026 — The UK Markey Cancer Center is enhancing its breast cancer treatment capabilities with the recent adoption of EnVisio, a novel wire-free surgical technology. This system is designed to assist surgeons in pinpointing and removing cancerous tumors with greater precision.

EnVisio operates similarly to a GPS navigation system, guiding surgeons during the removal process. This technology aims to improve upon traditional methods, which often relied on less precise localization techniques. By providing a digital map within the body, surgeons can more effectively identify the exact boundaries of a tumor, ensuring more complete removal while preserving healthy tissue.

The introduction of EnVisio at the Markey Cancer Center represents a step forward in oncological surgery. The system’s wire-free nature eliminates the need for the physical wires that were previously inserted into the breast to mark tumor locations. These wires could sometimes cause discomfort for patients and potentially shift, affecting accuracy. The new technology offers a solution that is both less invasive and more accurate.

This advancement is expected to contribute to better patient outcomes by enabling more targeted surgical interventions. Precise tumor localization is a critical factor in maximizing the chances of a successful surgery and minimizing the risk of recurrence. The precise guidance provided by EnVisio could lead to shorter, more effective procedures and potentially aid in faster patient recovery.

While the summary indicates this is a significant advancement, specific details regarding the timeline of its implementation, the number of patients who have benefited from the technology, or comparisons of outcomes with older methods were not provided. The exact capabilities and the full scope of EnVisio’s integration into the center’s surgical protocols are part of the ongoing rollout.


Story summarized from the original created by Ana Medina on www.lex18.com, see more information here.

About The Author